Katie Flaherty

885 total citations
11 papers, 118 citations indexed

About

Katie Flaherty is a scholar working on Epidemiology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katie Flaherty has authored 11 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Neurology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katie Flaherty's work include Acute Ischemic Stroke Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Intracerebral and Subarachnoid Hemorrhage Research (4 papers). Katie Flaherty is often cited by papers focused on Acute Ischemic Stroke Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Intracerebral and Subarachnoid Hemorrhage Research (4 papers). Katie Flaherty collaborates with scholars based in United Kingdom, Malaysia and Denmark. Katie Flaherty's co-authors include Philip M. Bath, Nikola Sprigg, Zhe Kang Law, Yulu Shi, Michael J. Thrippleton, Kirsten Shuler, Robert A. Dineen, Fergus Doubal, Joanna M. Wardlaw and Iona Hamilton and has published in prestigious journals such as Stroke, BMJ Open and Frontiers in Neurology.

In The Last Decade

Katie Flaherty

11 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katie Flaherty United Kingdom	7	67	57	32	31	21	11	118
Rob H. Lo Netherlands	2	83 1.2×	70 1.2×	14 0.4×	16 0.5×	47 2.2×	3	105
Hilde Hénon France	3	64 1.0×	68 1.2×	24 0.8×	12 0.4×	8 0.4×	4	95
Jan Vynckier Switzerland	5	67 1.0×	32 0.6×	17 0.5×	13 0.4×	39 1.9×	9	86
H. Tu Australia	3	85 1.3×	60 1.1×	24 0.8×	14 0.5×	47 2.2×	5	123
Suhas Bajgur United States	6	73 1.1×	114 2.0×	18 0.6×	31 1.0×	27 1.3×	9	166
Anna Pellisé Spain	6	39 0.6×	21 0.4×	35 1.1×	12 0.4×	33 1.6×	9	86
Xiue Wei China	7	53 0.8×	13 0.2×	16 0.5×	24 0.8×	23 1.1×	22	118
Mayumi Fukuda‐Doi Japan	6	65 1.0×	84 1.5×	24 0.8×	5 0.2×	28 1.3×	13	113
Bernhard Siepen Switzerland	5	52 0.8×	30 0.5×	16 0.5×	8 0.3×	16 0.8×	13	68
Basel Maamari Switzerland	3	48 0.7×	24 0.4×	13 0.4×	9 0.3×	23 1.1×	3	59

Countries citing papers authored by Katie Flaherty

Since Specialization

Citations

This map shows the geographic impact of Katie Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Flaherty more than expected).

Fields of papers citing papers by Katie Flaherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Flaherty. The network helps show where Katie Flaherty may publish in the future.

Co-authorship network of co-authors of Katie Flaherty

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Flaherty. A scholar is included among the top collaborators of Katie Flaherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Flaherty. Katie Flaherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ovesen, Christian, Janus Christian Jakobsen, Christian Gluud, et al.. (2021). Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign. Stroke. 52(8). 2629–2636. 18 indexed citations

Appleton, Jason P., Gordon W. Blair, Katie Flaherty, et al.. (2019). Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial. Frontiers in Neurology. 10. 723–723. 7 indexed citations

Blair, Gordon W., Jason P. Appleton, Katie Flaherty, et al.. (2019). Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial. EClinicalMedicine. 11. 34–43. 34 indexed citations

Dineen, Robert A., Stefan Pszczółkowski, Katie Flaherty, et al.. (2018). Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial. BMJ Open. 8(2). e019930–e019930. 6 indexed citations

Ovesen, Christian, Janus Christian Jakobsen, Christian Gluud, et al.. (2018). Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial. BMC Research Notes. 11(1). 379–379. 6 indexed citations

Blair, Gordon W., Jason P. Appleton, Katie Flaherty, et al.. (2018). Tolerability, Safety and Intermediary Pharmacological Effects of Cilostazol and Isosorbide Mononitrate, Alone and Combined, in Patients with Lacunar Ischaemic Stroke: The LACunar Intervention-1 (LACI-1) Trial. SSRN Electronic Journal. 1 indexed citations

Flaherty, Katie, Philip M. Bath, Robert A. Dineen, et al.. (2017). Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial. Trials. 18(1). 607–607. 10 indexed citations

Blair, Gordon W., Jason P. Appleton, Zhe Kang Law, et al.. (2017). Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination. International Journal of Stroke. 13(5). 530–538. 21 indexed citations

Bath, Philip M., Jane May, Katie Flaherty, et al.. (2017). Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack. Stroke Research and Treatment. 2017. 1–13. 9 indexed citations

10.

Bath, Philip M., Lisa J Woodhouse, Katie Flaherty, et al.. (2017). Abstract 189: Intensive Versus Guideline Antiplatelet Therapy For Preventing Recurrence In Patients With Acute Ischaemic Stroke Or TIA: Results In Minor Stroke And TIA From The Triple Antiplatelets For Reducing Dependency In Ischaemic Stroke (TARDIS) Trial. Stroke. 48(suppl_1). 2 indexed citations

11.

Bath, Philip M., Jason P. Appleton, Maia Beridze, et al.. (2016). Baseline characteristics of the 3096 patients recruited into the ‘Triple Antiplatelets for Reducing Dependency after Ischemic Stroke’ trial. International Journal of Stroke. 12(5). 524–538. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact